Article Text

Download PDFPDF

6ER-024 Potentially drug-related problems in a polymedicated population
  1. M Vázquez-Real,
  2. Á Alcalá-Soto,
  3. DS Ruiz-Pérez,
  4. MDV Sanchez Matamoros Piazza,
  5. JF Sierra-Sánchez
  1. Hospital Universitario Jerez de La Frontera, Pharmacy Department, Jerez de La Frontera, Spain


Background and importance Polymedication is becoming a growing problem nowadays in the general population. Drugs offer huge benefits treating acute and chronic conditions, but the more drugs are prescribed, the more potentially drug-related problems (PDRP) are found. Duplicities, prescription cascades, low therapeutical value drugs (LTVD), QT prolongation and anticholinergic potency are some of the main drug-related problems. Identifying target population with these problems can be a step forward to make pharmacological deprescription or modifications.

Aim and objectives The objective of this study was to investigate and quantify whether there are drug-related problems in a polimedicated population that belongs to a secondary level hospital as the first step of a pharmacist-led treatment revision.

Material and methods An observational transversal study in a hospital influence area of 450 000 inhabitants was done. Polymedication was defined as more than 15 prescribed drugs per patient. Sociodemographic and treatment data to quantify drug-related problems was extracted from digital clinical records. Excel (v. 2016) was used to process the data. Notes: duplicities were listed by comparing ATC level 5 (drug) and 4 (chemical subgrup); LTVD listed in local health-system documents; QT-prolonging drugs listed at CredibleMeds.

Results At September 2021, 2258 patients were found to be polymedicated. 1456 patients were female (64.5%). Median age was 75 (range 21–98) years. Drug-related problems found are listed in Table 1.

Abstract 6ER-024 Table 1

Drug-related problems found in the study population

Conclusion and relevance The results showed a high prevalence of PDRP, duplicities and LTVD being the most listed. This implies a high risk of adverse events or treatment misadequation. From this point with these data, a pharmacist-led revision programme could be a starting point to try to enhance treatment prescriptions.

References and/or acknowledgements

Conflict of interest No conflict of interest

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.